iMEDD, Inc. is a biomedical company dedicated to developing improved drug delivery and medical products based on proprietary bioMEMS, microfabrication and nanotechnology. The company's mission is to use NanoPORE membranes to develop products to meed medical needs for improved drug delivery. The first application is a sustained release implant for treatment of chronic hepatitis C